Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed-Reference-Cited by-同舟云学术

Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed

Published:2010-07 Issue:4 Volume:122 Page:39-48
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Citrome Leslie

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3810/pgm.2010.07.2174

Reference25 articles.

1. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

2. Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

3. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse

4. Therapeutic Options for Treatment-Resistant Depression

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QUETIAPINE;Prescriber's Guide;2024-04-18

2. OLANZAPINE;Prescriber's Guide;2024-04-18

3. Pimavanserin for the Treatment of Alzheimer’s Disease Psychosis: An Evaluation of the Clinical Importance of Efficacy Results;2022-08-12

4. The Modulation of Glutamatergic Signaling as a Potential Therapeutic Strategy for Major Depression;Glutamate and Neuropsychiatric Disorders;2022

5. Availability and use of number needed to treat (NNT) based decision aids for pharmaceutical interventions;Exploratory Research in Clinical and Social Pharmacy;2021-06